Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF 2 receptors without malaise and stress

British Journal of Pharmacology

Volumn 164, Issue 8, 2011, Pages 1959-1975

  Fekete, Ém ^a,b   Zhao, Y ^a   Szucs A ^c   Sabino, V ^a,d   Cottone, P ^a,d   Rivier, J ^e   Vale, W W ^e   Koob, G F ^a   Zorrilla, E P ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

anorexia; appetite; body weight; conditioned taste aversion; corticosterone; corticotropin releasing factor; corticotropin releasing hormone; CRF or CRH receptor; food intake; meal pattern or microstructure; obesity; stressin 1 A; urocortin

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; HORMONE RECEPTOR STIMULATING AGENT; STRESSIN1 A; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; UROCORTIN I; UROCORTIN II; UROCORTIN III;

ANIMAL EXPERIMENT; ANOREXIA; APPETITE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG POTENCY; FEEDING BEHAVIOR; FEMALE; FOOD AVERSION; FOOD INTAKE; INTEROCEPTIVE STRESS; KNOCKOUT MOUSE; MALAISE; MALE; MEAL; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; SYSTEMIC THERAPY; WEIGHT GAIN; WILD TYPE; WISTAR RAT;

ANIMALS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; FEEDING BEHAVIOR; FEMALE; MALE; MICE; MICE, KNOCKOUT; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PHYSIOLOGICAL; UROCORTINS;

EID: 81855228892     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01512.x     Document Type: Article

References (81)

1. Asakawa A, Inui A, Ueno N, Makino S, Fujimiya M, Fujino MA, et al,. (2001). Urocortin reduces oxygen consumption in lean and ob/ob mice. Int J Mol Med 7: 539-541.
2. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, et al,. (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24: 410-414. (Pubitemid 30187443)
3. Bale TL, Anderson KR, Roberts AJ, Lee KF, Nagy TR, Vale WW, (2003). Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology 144: 2580-2587. (Pubitemid 36629911)
4. Berger H, Heinrich N, Wietfeld D, Bienert M, Beyermann M, (2006). Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain. Br J Pharmacol 149: 942-947. (Pubitemid 44851718)
5. Beyermann M, Heinrich N, Fechner K, Furkert J, Zhang W, Kraetke O, et al,. (2007). Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain. Br J Pharmacol 151: 851-859. (Pubitemid 47075324)
6. Bittencourt JC, Sawchenko PE, (2000). Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J Neurosci 20: 1142-1156. (Pubitemid 30220471)
7. Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE, (1999). Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415: 285-312.
8. Brar BK, Chen A, Perrin MH, Vale W, (2004). Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology 145: 1718-1729. (Pubitemid 38402380)
9. Chan RK, Vale WW, Sawchenko PE, (2000). Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain. Neuroscience 101: 115-129.
10. Chatzaki E, Crowe PD, Wang L, Million M, Tache Y, Grigoriadis DE, (2004a). CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem 90: 309-316. (Pubitemid 38938216)
11. Chatzaki E, Murphy BJ, Wang L, Million M, Ohning GV, Crowe PD, et al,. (2004b). Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J Neurochem 88: 1-11. (Pubitemid 38030203)
12. Chatzaki E, Lambropoulou M, Constantinidis TC, Papadopoulos N, Tache Y, Minopoulos G, et al,. (2006). Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis. J Cell Physiol 209: 905-911. (Pubitemid 44665712)
13. Chen A, Blount A, Vaughan J, Brar B, Vale W, (2004). Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology 145: 2445-2457. (Pubitemid 38535072)
14. Chen A, Perrin M, Brar B, Li C, Jamieson P, Digruccio M, et al,. (2005). Mouse corticotropin-releasing factor receptor type 2 gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Mol Endocrinol 19: 441-458. (Pubitemid 40223468)
15. Cooper MS, Reeve JR, Jr, Abdalla MO, Moyer L, Raboin SJ, Green GM, et al,. (2008). Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complex. Brain Res 1205: 27-35.
16. Cottone P, Sabino V, Nagy TR, Coscina DV, Zorrilla EP, (2007). Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2. J Physiol 583: 487-504. (Pubitemid 47343486)
17. Cullen MJ, Ling N, Foster AC, Pelleymounter MA, (2001). Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology 142: 992-999. (Pubitemid 32202806)
18. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, et al,. (2004). Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145: 2687-2695. (Pubitemid 38686215)
19. De Fanti BA, Martinez JA, (2002). Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res 930: 37-41. (Pubitemid 34195626)
20. De Souza EB, (1995). Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20: 789-819. (Pubitemid 26050396)
21. Fekete EM, Zorrilla EP, (2007). Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol 28: 1-27. (Pubitemid 46533855)
22. Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szucs A, et al,. (2007). Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology 32: 1052-1068. (Pubitemid 46631977)
23. Fukuda T, Takahashi K, Suzuki T, Saruta M, Watanabe M, Nakata T, et al,. (2005). Urocortin 1, urocortin 3/stresscopin and corticotropin-releasing factor receptors in human adrenal and its disorders. J Clin Endocrinol Metab 90: 4671-4678. (Pubitemid 41159357)
24. Gourcerol G, Wang L, Wang YH, Million M, Tache Y, (2007). Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway. Endocrinology 148: 6115-6123. (Pubitemid 350146181)
25. de Groote L, Penalva RG, Flachskamm C, Reul JM, Linthorst AC, (2005). Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. J Neurochem 94: 45-56. (Pubitemid 40911391)
26. Harada S, Imaki T, Naruse M, Chikada N, Nakajima K, Demura H, (1999). Urocortin mRNA is expressed in the enteric nervous system of the rat. Neurosci Lett 267: 125-128. (Pubitemid 29251602)
27. Hsu SY, Hsueh AJ, (2001). Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7: 605-611. (Pubitemid 32448329)
28. Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, et al,. (1997). Urocortin expression in human pituitary gland and pituitary adenoma. J Clin Endocrinol Metab 82: 3842-3850. (Pubitemid 27509381)
29. Inoue K, Valdez GR, Reyes TM, Reinhardt LE, Tabarin A, Rivier J, et al,. (2003). Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J Pharmacol Exp Ther 305: 385-393. (Pubitemid 36373875)
30. Kastin AJ, Akerstrom V, (2002). Differential interactions of urocortin/corticotropin-releasing hormone peptides with the blood-brain barrier. Neuroendocrinology 75: 367-374. (Pubitemid 34639040)
31. Kissileff HR, (2000). Ingestive behavior microstructure, basic mechanisms and clinical applications. Neurosci Biobehav Rev 24: 171-172. (Pubitemid 30100442)
32. Kleiber M, Rogers TA, (1961). Energy metabolism. Annu Rev Physiol 23: 5-36.
33. Kotz CM, Wang C, Levine AS, Billington CJ, (2002). Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and -3 in rats. Am J Physiol Regul Integr Comp Physiol 282: R546-R551. (Pubitemid 34664606)
34. Kozicz T, Arimura A, (2002). Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23: 515-521. (Pubitemid 34143268)
35. Lawrence AJ, Krstew EV, Dautzenberg FM, Ruhmann A, (2002). The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain. Br J Pharmacol 136: 896-904. (Pubitemid 34836864)
36. Levin J, Serlin R, Seaman M, (1994). A controlled, poweful multiple-comparison strategy for several situations. Psychol Bull 115: 153-159. (Pubitemid 24976741)
37. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, et al,. (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98: 7570-7575. (Pubitemid 32567989)
38. Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, et al,. (2003). Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology 144: 3216-3224. (Pubitemid 36819924)
39. Lo CM, Zhang DM, Pearson K, Ma L, Sun W, Sakai RR, et al,. (2007). Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake. Am J Physiol Regul Integr Comp Physiol 293: R1490-R1494. (Pubitemid 47535766)
40. Lovenberg TW, Chalmers DT, Liu C, De Souza EB, (1995). CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136: 4139-4142.
41. Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E, (1995). Amylin decreases meal size in rats. Physiol Behav 58: 1197-1202. (Pubitemid 26003583)
42. Martinez V, Tache Y, (2006). CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 12: 4071-4088. (Pubitemid 44669761)
43. Martinez V, Wang L, Rivier JE, Vale W, Tache Y, (2002). Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 301: 611-617. (Pubitemid 34429975)
44. Martinez V, Wang L, Million M, Rivier J, Tache Y, (2004). Urocortins and the regulation of gastrointestinal motor function and visceral pain. Peptides 25: 1733-1744. (Pubitemid 39346215)
45. Nijsen M, Ongenae N, Meulemans A, Coulie B, (2005). Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain. Neurogastroenterol Motil 17: 423-432. (Pubitemid 40768915)
46. Ohata H, Shibasaki T, (2004). Effects of urocortin 2 and 3 on motor activity and food intake in rats. Peptides 25: 1703-1709. (Pubitemid 39346212)
47. Ott L, (1988). An Introduction to Statistical Methods and Data Analysis. PWS-Kent: Boston, MA.
48. Pan W, Kastin AJ, (2008). Urocortin and the brain. Prog Neurobiol 84: 148-156.
49. Pan W, Akerstrom V, Zhang J, Pejovic V, Kastin AJ, (2004). Modulation of feeding-related peptide/protein signals by the blood-brain barrier. J Neurochem 90: 455-461. (Pubitemid 38938230)
50. Patel JD, Ebenezer IS, (2008). The effect of intraperitoneal administration of leptin on short-term food intake in rats. Eur J Pharmacol 580: 143-152.
51. Pelleymounter MA, Joppa M, Ling N, Foster AC, (2004). Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25: 659-666. (Pubitemid 38681066)
52. Porcher C, Juhem A, Peinnequin A, Sinniger V, Bonaz B, (2005). Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine. Am J Physiol Gastrointest Liver Physiol 288: G1091-G1103. (Pubitemid 40563153)
53. Porcher C, Peinnequin A, Pellissier S, Meregnani J, Sinniger V, Canini F, et al,. (2006). Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. Peptides 27: 1464-1475. (Pubitemid 43767011)
54. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, et al,. (2001). Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98: 2843-2848. (Pubitemid 32209571)
55. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, et al,. (2002). Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45: 4737-4747.
56. Rivier J, Gulyas J, Kunitake K, DiGruccio M, Cantle JP, Perrin MH, et al,. (2007). Stressin(1)-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist. J Med Chem 50: 1668-1674. (Pubitemid 46564387)
57. Rosner B, (1995). Fundamentals of Biostatistics. Duxbury Press: Boston, MA.
58. Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H, (2004). Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J Clin Endocrinol Metab 89: 5352-5361. (Pubitemid 39518408)
59. Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H, (2005). Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions. Peptides 26: 1196-1206. (Pubitemid 40798076)
60. Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, et al,. (2004). Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 89: 965-970. (Pubitemid 38269919)
61. Simopoulos C, Christodoulou E, Lambropoulou M, Tsaroucha AK, Kakolyris S, Polychronidis A, et al,. (2009). Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Neuroendocrinology 89: 315-326.
62. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, et al,. (1996). Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273: 1561-1564. (Pubitemid 26301669)
63. Tabarin A, Diz-Chaves Y, Consoli D, Monsaingeon M, Bale TL, Culler MD, et al,. (2007). Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. Eur J Neurosci 26: 2303-2314. (Pubitemid 47620499)
64. Taché Y, Brunnhuber S, (2008). From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases. Ann N Y Acad Sci 1148: 29-41.
65. Taché Y, Martinez V, Million M, Maillot C, (2002). Role of corticotropin-releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome. Eur J Surg Suppl 587: 168-170.
66. Tanaka C, Asakawa A, Ushikai M, Sakoguchi T, Amitani H, Terashi M, et al,. (2009). Comparison of the anorexigenic activity of CRF family peptides. Biochem Biophys Res Commun 390: 887-891.
67. Tu H, Kastin AJ, Pan W, (2007). Corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 are both trafficking and signaling receptors for urocortin. Mol Endocrinol 21: 700-711.
68. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A, (2003). Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39: 401-407. (Pubitemid 36937043)
69. Vale W, Spiess J, Rivier C, Rivier J, (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394-1397. (Pubitemid 12243637)
70. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, et al,. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212.
71. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, et al,. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292.
72. Venihaki M, Sakihara S, Subramanian S, Dikkes P, Weninger SC, Liapakis G, et al,. (2004). Urocortin III, a brain neuropeptide of the corticotropin- releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J Neuroendocrinol 16: 411-422. (Pubitemid 38744835)
73. Vetter DE, Li C, Zhao L, Contarino A, Liberman MC, Smith GW, et al,. (2002). Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet 31: 363-369. (Pubitemid 35154444)
74. Wang C, Kotz CM, (2002). Urocortin in the lateral septal area modulates feeding induced by orexin A in the lateral hypothalamus. Am J Physiol Regul Integr Comp Physiol 283: R358-R367. (Pubitemid 34863884)
75. Wang L, Martinez V, Rivier JE, Tache Y, (2001). Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 281: R1401-R1410.
76. Yamauchi N, Otagiri A, Nemoto T, Sekino A, Oono H, Kato I, et al,. (2005). Distribution of urocortin 2 in various tissues of the rat. J Neuroendocrinol 17: 656-663. (Pubitemid 41341643)
77. Yuan PQ, Million M, Wu SV, Rivier J, Tache Y, (2007). Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil 19: 923-936. (Pubitemid 350060612)
78. Zorrilla EP, Tache Y, Koob GF, (2003). Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol Sci 24: 421-427. (Pubitemid 36952559)
79. Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, et al,. (2004). Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. J Pharmacol Exp Ther 310: 1027-1034. (Pubitemid 39108924)
80. Zorrilla EP, Inoue K, Fekete EM, Tabarin A, Valdez GR, Koob GF, (2005a). Measuring meals: structure of prandial food and water intake of rats. Am J Physiol Regul Integr Comp Physiol 288: R1450-R1467. (Pubitemid 40720696)
81. Zorrilla EP, Inoue K, Valdez GR, Tabarin A, Koob GF, (2005b). Leptin and post-prandial satiety: acute central leptin more potently reduces meal frequency than meal size in the rat. Psychopharmacology (Berl) 177: 324-335. (Pubitemid 40137293)